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Objective: To determine graft and patient survival, rate of cardiac events (myocardial infarction, revascularization, or cardiac death) and 
hospitalization for congestive heart failure (CHF) in kidney transplant (KT) recipients with low left ventricular ejection fraction (EF) prior to 
transplantation.
Methods: We retrospectively studied all patients who underwent KT at our center between 2001 and 2005. Low EF was defined as less than 50% 
EF by cardiac imaging. All patients meeting criteria for cardiac testing and those with low EF underwent screening for cardiac ischemia and treatment 
per hospital protocol during pre transplant evaluation. Data were collected for one year following transplantation.
Results: Table 1 shows demographics (N=254) pre KT and outcomes post KT. Significantly more coronary artery disease(CAD) and CHF were 
present pre KT in the low EF group. Post KT, the low EF group was significantly more likely to have a hospitalization for CHF. Only one patient (low EF 
group) had more than one CHF hospitalization. The low EF group was also more likely to have a cardiac event (not significant, p = 0.145). Graft loss, 
glomerular filtration rate(GFR) and all cause death were not different between the groups. 
Low EF
N=37
Normal EF
N= 217
P value
Age(years) 50.8 ± 11.3 52.4 ±13.2 0.502
Gender (males) 75.7% 53.7% 0.013
Race
AA
Whites
other
51.4%
43.2%
5.4%
60.6%
31.0%
8.3%
0.326
CAD 29.7% 14.7% 0.025
CHF 35.1% 6.5% <0.001
DM 36.1% 47.5% 0.205
Hypertension 94.6% 94.0% 1.000
Outcomes
CHF
hospitalization
13.3% 2.6% 0.022
GFR at 12 mon 53.9 ± 22.2 54.1 ± 20.8 0.975
All-cause death 12.1% 10.6% 0.764
Graft loss 17.1% 16.2% 0.888
Conclusion: Despite the higher rate of CHF hospitalization and cardiac events in the low EF group, the GFR, graft loss, and all cause death at 12 
months post transplant were not significantly different between the two groups. Patients with low EF should not be excluded from transplantation.
